Indivior (LON:INDV) Shares Down 15.7% – Should You Sell?

Indivior PLC (LON:INDV) was down 15.7% on Thursday . The stock traded as low as GBX 548.71 ($6.90) and last traded at GBX 732 ($9.21). Approximately 1,888,371 shares traded hands during mid-day trading, an increase of 166% from the average daily volume of 709,477 shares. The stock had previously closed at GBX 868 ($10.92).

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 1,800 ($22.65) target price on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Price Performance

The stock’s 50 day moving average is GBX 928.06 and its two-hundred day moving average is GBX 853.71. The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The stock has a market capitalization of £1.14 billion, a PE ratio of -606.93, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.